Answers are grounded in this paper and cite their sources.
The influence of the mucin-1 (Muc-1) receptor in cancer progression and its association with a poor prognosis make it a potentially ideal target in pharmacology. However, the mechanism of action and its interaction with the cellular membrane are not fully characterized at a proper atomistic level. In this contribution, using long all-atom molecular dynamics simulations largely exceeding the µs time-scale, we analyze the interaction of the membrane-embedded Muc-1 β subunit with a peptide mimicking the Muc-1 α interface. Despite showing the stability of the protein/peptide aggregate, which can be exploited for drug delivery, we also show and characterize the long-range structural modification of the transmembrane subunit upon peptide binding. This represents the first modeling of the initial alteration of the Muc-1 conformational landscape induced by the formation of the α/β heterodimer.
No takes yet. Share an insight, caveat, or question.
Magnouloux et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: